STOCK TITAN

Amgen’s Arleen Paulino reports 4,455 directly held shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

Amgen Inc. EVP, Operations Arleen Paulino reported 4,455 directly held common shares, including 2,181 restricted stock units and 66 dividend equivalents, plus 2,039.9774 shares represented by interests in the company’s stock fund through the 401(k) Plan. Her report also lists non-qualified stock options, including 5,314 options at a $236.36 exercise price, vested and exercisable, and 7,166 options at $235.97, of which 4,729 are vested. The first tranche expires May 5, 2030; the latter expires May 2, 2033, with its remaining options scheduled to vest and become exercisable on May 2, 2027. Other listed tranches have differing exercise prices and vesting schedules, including installments beginning in 2027.

Insider Paulino Arleen
Role EVP, Operations
Type Security Shares Price Value
Holding Nqso (Right to Buy) F4 -- -- --
Holding Nqso (Right to Buy) F5 -- -- --
Holding Nqso (Right to Buy) F6 -- -- --
Holding Nqso (Right to Buy) F7 -- -- --
Holding Nqso (Right to Buy) F8 -- -- --
Holding Nqso (Right to Buy) F9 -- -- --
Holding Nqso (Right to Buy) F10 -- -- --
Holding Nqso (Right to Buy) F11 -- -- --
Holding Common Stock F1, F2 -- -- --
Holding Common Stock F3 -- -- --
Holdings: Nqso (Right to Buy) — 81,265 options (Direct); Common Stock — 4,455 shares (Direct); Common Stock — 2,039.9774 shares (Indirect, 401(k) Plan)
Footnotes (11)
  1. F1. These shares include 2,181 Restricted Stock Units (RSUs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan). Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  2. F2. These shares include 66 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  3. F3. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
  4. F4. 5,314 of these non-qualified stock options have vested and are exercisable.
  5. F5. 5,434 of these non-qualified stock options have vested and are exercisable.
  6. F6. 40,595 of these non-qualified stock options have vested and are exercisable.
  7. F7. 7,070 of these non-qualified stock options have vested and are exercisable.
  8. F8. 4,729 of these non-qualified stock options have vested and the remaining options will vest and become exercisable on 5/2/2027.
  9. F9. 1,427 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in two annual installments, commencing on 5/7/2027.
  10. F10. 1,553 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in three annual installments, commencing on 5/6/2027.
  11. F11. These non-qualified stock options will vest and become exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Direct common shares 4,455 shares Reported directly held; includes 2,181 restricted stock units and 66 dividend equivalents
401(k) Plan stock fund interests 2,039.9774 shares Indirect ownership through the company’s 401(k) Plan
Non-qualified stock options 5,314 underlying shares; $236.36 exercise price Vested and exercisable; expiration May 5, 2030
Non-qualified stock options 5,434 underlying shares; $239.64 exercise price Vested and exercisable; expiration April 30, 2031
Non-qualified stock options 40,595 underlying shares; $230.15 exercise price Vested and exercisable; expiration August 6, 2031
Non-qualified stock options 7,070 underlying shares; $230.92 exercise price Vested and exercisable; expiration May 2, 2032
Non-qualified stock options 7,166 underlying shares; $235.97 exercise price 4,729 vested; expiration May 2, 2033
Non-qualified stock options 6,214 underlying shares; $270.44 exercise price 1,553 vested; expiration May 6, 2035
non-qualified stock options financial
"5,314 of these non-qualified stock options have vested and are exercisable"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Restricted Stock Units (RSUs) financial
"These shares include 2,181 Restricted Stock Units (RSUs)"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 66 Dividend Equivalents (DEs)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AMGN shares did Arleen Paulino report holding?

Arleen Paulino reported 4,455 directly held common shares and 2,039.9774 shares through the 401(k) Plan. The direct position includes 2,181 restricted stock units and 66 dividend equivalents. The plan shares represent interests in Amgen’s stock fund.

What vesting schedules did Arleen Paulino report for AMGN options?

Her reported option positions have different vesting terms. 4,729 of the 7,166 options at $235.97 are vested; the remaining options will vest and become exercisable on May 2, 2027. Of 4,326 options at $300.30, 1,427 are vested and the remaining options vest in two annual installments beginning May 7, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Paulino Arleen

(Last)(First)(Middle)
ONE AMGEN CENTER DRIVE

(Street)
THOUSAND OAKS CALIFORNIA 91320

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
11/16/2026
3. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Operations
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock4,455(1)(2)D
Common Stock2,039.9774(3)I401(k) Plan
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Nqso (Right to Buy)05/05/2022(4)05/05/2030Common Stock5,314$236.36D
Nqso (Right to Buy)04/30/2023(5)04/30/2031Common Stock5,434$239.64D
Nqso (Right to Buy)08/06/2023(6)08/06/2031Common Stock40,595$230.15D
Nqso (Right to Buy)05/02/2024(7)05/02/2032Common Stock7,070$230.92D
Nqso (Right to Buy)05/02/2025(8)05/02/2033Common Stock7,166$235.97D
Nqso (Right to Buy)05/07/2026(9)05/07/2034Common Stock4,326$300.3D
Nqso (Right to Buy)05/06/2026(10)05/06/2035Common Stock6,214$270.44D
Nqso (Right to Buy)05/05/2027(11)05/05/2036Common Stock5,146$329.59D
Explanation of Responses:
1. These shares include 2,181 Restricted Stock Units (RSUs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan). Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
2. These shares include 66 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
3. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
4. 5,314 of these non-qualified stock options have vested and are exercisable.
5. 5,434 of these non-qualified stock options have vested and are exercisable.
6. 40,595 of these non-qualified stock options have vested and are exercisable.
7. 7,070 of these non-qualified stock options have vested and are exercisable.
8. 4,729 of these non-qualified stock options have vested and the remaining options will vest and become exercisable on 5/2/2027.
9. 1,427 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in two annual installments, commencing on 5/7/2027.
10. 1,553 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in three annual installments, commencing on 5/6/2027.
11. These non-qualified stock options will vest and become exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Andrea A. Robinson, attorney-in-fact for Ms. Paulino11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading